Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensively Drug-Resistant”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Early research (Phase 1)Study completedNCT04309656
What this trial is testing

Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid

Who this might be right for
Multi-drug Resistant Tuberculosis
Global Alliance for TB Drug Development 48
Testing effectiveness (Phase 2)Study completedNCT04179500
What this trial is testing

A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+2 more
Global Alliance for TB Drug Development 26
Large-scale testing (Phase 3)Study completedNCT01061593
What this trial is testing

Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV

Who this might be right for
TuberculosisHIV
Lisichansk Regional Tuberculosis Dispensary 269
Large-scale testing (Phase 3)WithdrawnNCT01600963
What this trial is testing

Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis

Who this might be right for
Multi-drug Resistant Tuberculosis
Janssen Infectious Diseases BVBA
Not applicableUnknownNCT04352855
What this trial is testing

Ceftolozane-tazobactam for the Treatment of Respiratory Infections Due to Extensively Drug-resistant Pseudomonas Aeruginosa Among Critically Ill Patients: a Retrospective Study.

Who this might be right for
Ventilator Associated PneumoniaAntibiotic Resistant Infection
Semmelweis University 55
Post-approval studies (Phase 4)Study completedNCT01521364
What this trial is testing

Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients

Who this might be right for
Multidrug-resistant TuberculosisExtensively Drug-resistant Tuberculosis
University Medical Center Groningen 7
Testing effectiveness (Phase 2)Study completedNCT00685360
What this trial is testing

A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug ResistantExtensively Drug-Resistant Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 481
Not applicableEnded earlyNCT01381757
What this trial is testing

Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali

Who this might be right for
Tuberculosis, PulmonaryMycobacterium TuberculousAntitubercular Agents+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 34
Large-scale testing (Phase 3)Study completedNCT04207112
What this trial is testing

Economic Evaluation of New MDR TB Regimens

Who this might be right for
Multi-drug Resistant TuberculosisExtensively Drug-Resistant TuberculosisPulmonary Tuberculoses
Medecins Sans Frontieres, Netherlands 73
Not applicableStudy completedNCT03622918
What this trial is testing

Colistin-rifampin Combination and Colistin Monotherapy in Extensively Drug-resistant Acinetobacter Baumannii

Who this might be right for
ColistinRifampinAcinetobacter Infections
Gangnam Severance Hospital 9
Large-scale testing (Phase 3)Study completedNCT06739382
What this trial is testing

Management of Ventilation Acquired Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center

Who this might be right for
Ventilation Acquired Pneumonia
Beni-Suef University 64
Not applicableStudy completedNCT05175794
What this trial is testing

Triage Test for All Oral DR-TB Regimen (TRiAD Study)

Who this might be right for
Drug Resistant TuberculosisMDR-TBXDR-TB+1 more
Centre for the AIDS Programme of Research in South Africa 786
Not applicableStudy completedNCT03767374
What this trial is testing

Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs

Who this might be right for
Bacterial InfectionsHIV Infections
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 2,186
Testing effectiveness (Phase 2)Study completedNCT00664313
What this trial is testing

TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB

Who this might be right for
Multi-drug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
Centers for Disease Control and Prevention 36
Not applicableApproved For MarketingNCT01464762
What this trial is testing

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA
Testing effectiveness (Phase 2)Study completedNCT01222338
What this trial is testing

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

Who this might be right for
Tuberculosis
Lisichansk Regional Tuberculosis Dispensary 123
Not applicableStudy completedNCT04342598
What this trial is testing

Case Control Study of Vitamin D Status and Adult Multidrug-resistant Pulmonary Tuberculosis in Maharashtra, India

Who this might be right for
Multi-drug Resistant Tuberculosis
Harvard School of Public Health (HSPH) 352
Testing effectiveness (Phase 2)Study completedNCT00727844
What this trial is testing

Linezolid to Treat Extensively-Drug Resistant Tuberculosis

Who this might be right for
Pulmonary TuberculosisMultidrug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 41
Post-approval studies (Phase 4)UnknownNCT02328183
What this trial is testing

Efficacy of Polymyxin B Against Infections Caused by Extensively Drug-resistant (XDR) Gram-Negative Bacteria

Who this might be right for
Hospital Infection
Mahidol University 100
Post-approval studies (Phase 4)Study completedNCT07445282
What this trial is testing

This Randomized Controlled Trial Evaluates the Comparative Efficacy of Intravenous Meropenem Alone Versus Intravenous Meropenem Combined With Oral Azithromycin in Children Aged 6 Months to Under 5 Years Diagnosed With Blood Culture-confirmed Extensively Drug-resistant Uncomplicated Typhoid Fever

Who this might be right for
Extensively Drug-Resistant Typhoid FeverTyphoid FeverSalmonella Typhi Infection
Sheikh Zayed Medical College 90
Load More Results